FDA approves Moderna’s mRNA-based vaccine for the flu
Original article ↗B.I.A.S. ANALYSIS
CENTER
LEFTCENTERRIGHT
Signal breakdown
Heuristic (v1/v3)
0.00 · CENTER
ML v2 (DistilBERT)
0.000 · CENTER
Ensemble
0.000 · CENTER
🏦 Source Intelligence
Rolling outlet bias
CENTER
avg -0.076
4,770 articles tracked
7-day bias trend
LcenterR
Article Excerpt
The shot, named mFlusiva, is intended for adults age 50 or older. Moderna said late Wednesday that it expects some of its new version to be available soon at select retailers.
Read full article at Global News ↗
How we scored this article
WTF uses a two-tier system: every article gets a heuristic bias score from keyword analysis, and priority articles (high overlap across 3+ outlets or strong heuristic signal) get full LLM analysis from B.I.A.S. and V.E.R.I.F.Y.
Analyzed by
B.I.A.S.
V.E.R.I.F.Y.
L.O.C.A.L.
pending
Aug 6, 2026
📰
🔒 Unlock — Starter+
1 outlet covered this story
Side-by-side comparison · bias by outlet · framing analysis